Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Mixed Asset Passive

RISE Healthcare Fixed Income Balanced (253290)

Update : 2025.02.14

NAV

12,331KRW

+81.4상승 (0.66%)

Market Price per share (KRW)

12,310KRW

+75상승 (0.61%)

※ t-1 last price

trading volume

9,795shares

AUM

KRW 14.7billion

Share it

RISE Healthcare Fixed Income Balanced (253290)

Overview Performance Holdings

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2025.02.14
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290) 		FnGuide HealthCare Mix Index 2016.09.23 200,000 14,796,674,122
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 12,310
※ t-1 last price 		12,330 9,795
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare Fixed Income Balanced ETF

(253290) 		FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
14,796,674,122 하나은행
Market Price per share (KRW) iNAV per share (KRW)
12,310
※ t-1 last price 		12,330
Trading Volume (shares)
9,795
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2025-02-14
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB03000-2909(24-7) 27.88
2 KTB03875-2612(23-10) 20.98
3 RISE HealthCare 12.34
4 RISE KTB 8.54
5 KTB03250-2706(24-4) 6.93
6 원화예금 3.54
7 F 202503 2.90
8 SAMSUNG BIOLOGICS 2.21
9 Alteogen 2.15
10 Yuhan 1.94

proportion by sectors

*The proportion of investment stocks

Update : 2025.02.14
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2024-12-09 2024-12-11 90
2024-06-07 2024-06-11 40
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11

Performance

performance

excel download

Update : 2025-02-14

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV 1.63 3.04 3.26 8.11 13.72 2.57 27.91
Benchmark Index 1.64 3.29 3.91 9.69 17.25 2.67 34.65
Outperformance -0.02 -0.25 -0.66 -1.58 -3.53 -0.11 -6.74

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2025.02.14 12,310 0.612상승 12,330.56 0.664상승
2025.02.13 12,235 -0.163하락 12,249.14 -
2025.02.12 12,255 -0.527하락 12,249.13 -0.524하락
2025.02.11 12,320 -0.081하락 12,313.72 -0.145하락
2025.02.10 12,330 -0.242하락 12,331.65 -0.171하락
2025.02.07 12,360 -0.080하락 12,352 -0.143하락
2025.02.06 12,370 0.773상승 12,369.67 0.796상승
2025.02.05 12,275 0.697상승 12,271.88 0.689상승
2025.02.04 12,190 0.494상승 12,187.85 0.535상승
2025.02.03 12,130 -0.817하락 12,122.91 -0.900하락
2025.01.31 12,230 0.163상승 12,232.31 0.153상승
2025.01.24 12,210 0.246상승 12,211.25 0.241상승
2025.01.23 12,180 - 12,181.86 0.046상승
2025.01.22 12,180 0.246상승 12,176.21 0.238상승
2025.01.21 12,150 0.164상승 12,147.2 0.154상승
2025.01.20 12,130 -0.041하락 12,128.41 -0.076하락
2025.01.17 12,135 -0.205하락 12,136.95 -0.318하락
2025.01.16 12,160 0.787상승 12,175.75 0.928상승
2025.01.15 12,065 -0.658하락 12,063.73 -0.568하락

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value 		Weight(%) Market price (KRW)
1 KTB03000-2909(24-7) KR103501GE98 666,666,666 27.88 683,089,999
2 KTB03875-2612(23-10) KR103501GDC8 500,000,000 20.98 514,024,500
3 RISE HealthCare KR7253280002 20,641 12.34 302,287,445
4 RISE KTB KR7114100001 1,900 8.54 209,247,000
5 KTB03250-2706(24-4) KR103501GE64 166,666,667 6.93 169,838,167
6 원화예금 KRD010010001 86,776,173 3.54 86,776,173
7 F 202503 KR4165W30008 0.67 2.9 71,112,622
8 SAMSUNG BIOLOGICS KR7207940008 46 2.21 54,234,000
9 Alteogen KR7196170005 142 2.15 52,611,000
10 Yuhan KR7000100008 378 1.94 47,476,800
11 HLB KR7028300002 629 1.91 46,734,700
12 Celltrion KR7068270008 251 1.82 44,652,900
13 SKBP KR7326030004 242 1.24 30,346,800
14 SCD KR7000250001 124 0.91 22,344,800
15 HanmiPharm KR7128940004 56 0.61 14,980,000
16 PharmaResearch KR7214450009 55 0.61 14,987,500
17 HANALL BIOPHARMA KR7009420001 313 0.5 12,191,350
18 SKBS KR7302440003 235 0.46 11,291,750
19 ST Pharm KR7237690003 112 0.39 9,553,600
20 Celltrionph KR7068760008 178 0.37 9,149,200
21 CLASSYS KR7214150005 155 0.32 7,827,500
22 SEEGENE KR7096530001 284 0.27 6,517,800
23 GC Corp KR7006280002 49 0.27 6,551,300
24 CHONGKUNDANG KR7185750007 76 0.25 6,194,000
25 MedyTox KR7086900008 48 0.24 5,798,400
26 HLBPHARMA KR7047920004 240 0.23 5,736,000
27 Pharmicell KR7005690003 496 0.22 5,366,720
28 DAEWOONG PHARM KR7069620003 40 0.22 5,432,000
29 Hanmi Science KR7008930000 180 0.21 5,175,000
30 Binex KR7053030003 255 0.21 5,049,000
31 HK inno.N KR7195940002 126 0.18 4,473,000
32 DENTIUM KR7145720009 58 0.17 4,187,600
33 CHA Biotech KR7085660009 353 0.16 4,027,730
34 Daewoong KR7003090008 174 0.15 3,601,800
35 Boryung KR7003850005 331 0.14 3,379,510
36 BIONEER KR7064550007 197 0.14 3,402,190
37 DongKook Pharm KR7086450004 206 0.13 3,174,460
38 i-SENS KR7099190001 186 0.13 3,106,200
39 SD Biosensor KR7137310009 316 0.13 3,302,200
40 EuBio KR7206650004 275 0.13 3,104,750
41 SELVAS AI KR7108860008 210 0.13 3,292,800
42 T&L KR7340570001 41 0.13 3,234,900
43 JWPHARMA KR7001060003 118 0.11 2,743,500
44 BioPlus KR7099430001 352 0.1 2,478,080
45 Donga ST KR7170900005 43 0.09 2,119,900
46 WONTECH KR7336570007 381 0.09 2,179,320
47 GC CELL KR7144510005 70 0.06 1,561,000
48 Aprogen KR7007460009 1,324 0.04 990,352
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.